Turmeric compound tested for cancer drug joint pain

NCT ID NCT03865992

Ongoing Symptom relief Sponsor: City of Hope Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether curcumin, the active ingredient in turmeric, can reduce joint pain caused by aromatase inhibitors in breast cancer survivors. 42 postmenopausal women will receive either curcumin or a placebo for 3 months. Researchers will measure changes in pain and overall well-being using standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: curcumin (a dietary supplement from turmeric)
What this could lead to: If it works, this could point toward a natural way to reduce joint pain in breast cancer survivors taking aromatase inhibitors.
What could go wrong: This is a very small pilot study (42 people) with no phase, so results are preliminary. Curcumin may not work better than placebo, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arthralgia arthropathy breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER JOINT PAIN

Contacts and locations

Locations

City of Hope Medical Center

Duarte, California, 91010, United States
City of Hope Rancho Cucamonga

Rancho Cucamonga, California, 91730, United States
City of Hope South Pasadena

South Pasadena, California, 91030, United States
Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.